INJECTION SITE VASCULITIS

INJECTION SITE VASCULITIS was reported 57 times

INJECTION SITE VASCULITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anti-coagulant [EPC] 1 0.0003
1 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
2 Antimycobacterial [EPC] 2 0.0001
3 Oxazolidinone Antibacterial [EPC] 2 0.0001
4 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
5 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
6 PCSK9 Inhibitor [EPC] 1 0.0000
7 Proteasome Inhibitor [EPC] 4 0.0000
8 Penem Antibacterial [EPC] 1 0.0000
9 Nucleoside Metabolic Inhibitor [EPC] 8 0.0000
10 Interleukin-17A Antagonist [EPC] 1 0.0000
11 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
12 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
13 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
14 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
15 Alkylating Drug [EPC] 3 0.0000
16 Anti-IgE [EPC] 1 0.0000
17 Interferon beta [EPC] 2 0.0000
18 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
19 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
20 Expectorant [EPC] 1 0.0000
21 GLP-1 Receptor Agonist [EPC] 2 0.0000
22 Osmotic Laxative [EPC] 1 0.0000
23 Corticosteroid [EPC] 4 0.0000
24 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
25 Insulin Analog [EPC] 1 0.0000
26 Loop Diuretic [EPC] 1 0.0000
27 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000